ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.19
0.00%
US Tech 100
21,136.00
0.44%
S&P 500
6,013.13
-1.71%
US Dollar vs CAD
1.42109
-0.17%
Bitcoin
95,782.39
-0.51%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Liquidia Corporation (LQDA)

  7. Liquidia Corporation (LQDA) News

LQDA

Liquidia (LQDA)

Liquidia Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LQDA
DateTimeSourceHeadlineSymbolCompany
02/12/20254:34PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LQDALiquidia Corporation
01/23/20254:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
01/14/20253:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
01/14/20253:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
01/14/20253:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
01/08/20257:00AMGlobeNewswire Inc.Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
12/03/20248:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
12/03/20248:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
11/13/20246:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LQDALiquidia Corporation
11/13/20245:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
11/13/20245:30AMGlobeNewswire Inc.Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
11/12/20247:00AMGlobeNewswire Inc.Liquidia to Present at the Stifel 2024 Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
11/06/20247:00AMGlobeNewswire Inc.Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024NASDAQ:LQDALiquidia Corporation
11/04/20247:00AMGlobeNewswire Inc.Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024NASDAQ:LQDALiquidia Corporation
10/22/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
10/18/20242:31PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:LQDALiquidia Corporation
10/15/20247:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
10/15/20247:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
10/15/20247:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
10/07/20249:00AMGlobeNewswire Inc.United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ PatentNASDAQ:LQDALiquidia Corporation
10/02/20245:00AMGlobeNewswire Inc.Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)NASDAQ:LQDALiquidia Corporation
09/30/20247:00AMGlobeNewswire Inc.Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual MeetingNASDAQ:LQDALiquidia Corporation
09/17/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
09/16/20248:41AMGlobeNewswire Inc.Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 MillionNASDAQ:LQDALiquidia Corporation
09/12/20243:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
09/11/20243:41PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:LQDALiquidia Corporation
09/11/20247:33AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
09/11/20247:29AMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:LQDALiquidia Corporation
09/11/20247:26AMGlobeNewswire Inc.Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing AgreementNASDAQ:LQDALiquidia Corporation
09/11/20247:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
 Showing the most relevant articles for your search:NASDAQ:LQDA

Your Recent History

COIN
XRPUSD
Ripple
USOTC
HIRU
Hiru (PK)
NASDAQ
COOP
Mr Cooper
USOTC
AZRH
Azure (PK)
USOTC
ASII
Accredited Solutions (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
RDGL
Vivos (QB)
USOTC
RNVA
Rennova Health (CE)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
NBRI
North Bay Resources (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads